Chemfab Alkalis financials

·ChemicalsChart ›
Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹75.6cr−1.2% on Q2 FY26
Net profit
−₹2.1cr−₹2.0 cr in Q2 FY26
EBITDA margin
9.3%+2.2 pts on Q2 FY26
EPS
−₹1.47−₹1.40 in Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue75.676.6−1.2%
EBITDA7.05.5+28.8%
EBITDA margin9.3%7.1%+2.2 pts
Profit before tax−2.9−1.3—
Net profit−2.1−2.0—
EPS−₹1.47−₹1.40—

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹75.6 crNet profit₹−2.1 crNet margin−2.8%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
428————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.113.621.07.769.2
12312382.518.20.0
551————
292311334327331
—−7.0%+2.2%−1.2%—
27.627.243.753.9110
9.5%8.8%13.1%16.5%33.3%
−3.5−1.27.431.587.5
−0.3−3.4−6.926.364.6
−0.1%−1.1%−2.1%8.0%19.5%
−₹0.24−₹2.38−₹4.83₹18.31₹44.93
—+50.6%−126.4%−59.2%—
—38.139.912692.6
—−91.2−1130.0−57.6
−53.1−53.1−73.512635.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CHEMFAB₹298.00

Chemfab Alkalis Limited

· Chemicals
₹ CrorePeersPRIMOPLASTIBLENMANORGKRONOXJAYAGROGNLORDSCHLODMCCSRHHYPOLTDMcap ₹428 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————428.3
- Cash, Equiv & ST Investments69.27.721.013.60.1
+ Total Debt0.018.282.5123.0123.0
Enterprise Value————551.2
Revenue331.4327.3334.4311.0291.7
Growth %, YoY—-1.2+2.2-7.0—
EBITDA110.553.943.727.227.6
Margin %33.3416.4713.088.759.47
EBIT87.531.57.4-1.2-3.5
Net Income64.626.3-6.9-3.4-0.3
Margin %19.498.04-2.08-1.10-0.12
EPS, Adj (current shares)44.9318.31-4.83-2.38-0.24
Growth %, YoY—-59.2-126.4+50.6—
Cash from Operations92.6126.239.938.1—
Capital Expenditures-57.6-0.0-113.4-91.2—
Free Cash Flow35.0126.2-73.5-53.1-53.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Chemfab Alkalis financials and key ratios

Prices at the 30 October 2026 close · figures from the company's filings with NSE

Chemfab Alkalis (NSE: CHEMFAB) had a market capitalisation of ₹419 crore at the 30 October 2026 close (₹291.35 a share) and a price-to-book ratio of 1.11. In FY26 its consolidated net loss was ₹3.4 crore on revenue of ₹311 crore; in Q2 FY27 (July–September 2026) it was a loss of ₹2.1 crore. Its debt-to-equity ratio was 0.37 on 30 September 2026. Promoters held 72.13% of the shares on 30 September 2026.

Chemfab Alkalis Q2 FY27 results
filed 28 October 2026
Share price used
₹291.35 · 30 October 2026 close
Latest balance sheet
30 September 2026
Shareholding pattern
30 September 2026

Chemfab Alkalis at a glance · consolidated

Market cap
₹419 Crat ₹291.35 · 30 Oct close
PE ratio
n/aloss over the last 4 quarters
Price to book (PB)
1.11book value ₹262.68 a share
ROE (FY26)
−0.9%+0.9 pts vs FY25ROCE −0.3%
Debt to equity
0.37net debt ₹140 Cr
Promoter holding
72.13%unchanged vs 30 Jun 202630 September 2026
Dividend yield
0.43%₹1.25 a share in 12 months
Net worth
₹378 Cr−0.4% vs 30 Sep 202530 September 2026
Free cash flow (FY26)
−₹53.1 Cr

Questions

What is the Chemfab Alkalis PE ratio today?

Chemfab Alkalis' PE ratio is not meaningful at the 30 October 2026 close: its consolidated net profit over the last four quarters (Q3 FY26 to Q2 FY27) was a loss of ₹34 lakh, and a price-to-earnings ratio needs positive earnings. Its market capitalisation was ₹419 crore at ₹291.35 a share.

What is the Chemfab Alkalis PB ratio (price to book value)?

Chemfab Alkalis' price-to-book (PB) ratio is 1.11 at the 30 October 2026 close: a market capitalisation of ₹419 crore divided by shareholders' equity (book value) of ₹378 crore on 30 September 2026. That is a book value of ₹262.68 per share against a share price of ₹291.35.

What is the Chemfab Alkalis book value per share?

Chemfab Alkalis' book value per share was ₹262.68 on 30 September 2026: shareholders' equity of ₹378 crore divided by the 1.44 crore shares in issue, down 0.4% from ₹263.83 a year earlier. The share price at the 30 October 2026 close was ₹291.35.

What is the Chemfab Alkalis market cap?

Chemfab Alkalis' market capitalisation was ₹419 crore at the 30 October 2026 close: 1.44 crore shares at ₹291.35 each.

What is the Chemfab Alkalis EPS?

Chemfab Alkalis' basic earnings per share (EPS) were −₹2.38 in FY26, against −₹4.86 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to −₹0.23.

What is the Chemfab Alkalis dividend in 2026 and its record date?

In 2026, Chemfab Alkalis has declared one dividend: ₹1.25 with record date 2 September 2026.

Is Chemfab Alkalis debt free?

No. Chemfab Alkalis had borrowings of ₹141 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.37. Its cash and current investments were ₹95 lakh, so its net debt was ₹140 crore.

What is the Chemfab Alkalis debt to equity ratio?

Chemfab Alkalis' debt-to-equity ratio was 0.37 on 30 September 2026: borrowings of ₹141 crore against total equity of ₹378 crore. A year earlier, on 30 September 2025, it was 0.28.

What is the Chemfab Alkalis promoter holding?

Promoters held 72.13% of Chemfab Alkalis on 30 September 2026, unchanged from the previous quarter and down 0.05 percentage points from 72.18% a year earlier, according to the shareholding pattern filed with NSE.

What is the Chemfab Alkalis net worth?

Chemfab Alkalis' net worth — shareholders' equity in its consolidated balance sheet — was ₹378 crore on 30 September 2026, down 0.4% from ₹379 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹419 crore at the 30 October 2026 close.

What is the Chemfab Alkalis dividend yield?

Chemfab Alkalis' dividend yield is 0.43% at the 30 October 2026 close: dividends of ₹1.25 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹291.35. They were ₹1.25 on 2 September 2026.

What is the Chemfab Alkalis free cash flow?

In FY26, Chemfab Alkalis generated ₹38.1 crore of cash from operations and spent ₹91.2 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹53.1 crore. In FY25 it was −₹73.5 crore.

What is the Chemfab Alkalis ROE and ROCE?

In FY26, Chemfab Alkalis' return on equity (ROE) was −0.9% and its return on capital employed (ROCE) was −0.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −1.8% and ROCE 1.7%.

What is the Chemfab Alkalis shareholding pattern?

On 30 September 2026, Chemfab Alkalis' shares were held by promoters 72.13%, foreign portfolio investors (FII/FPI) 0.04%, domestic institutions (DII) 0.07% (including mutual funds at 0.07%) and retail and other non-institutional investors 27.75%. Over the year, FII holding was up 0.04 percentage points from 0.00% and DII holding was down 0.20 percentage points from 0.27%.

What are the Chemfab Alkalis latest quarterly results?

Chemfab Alkalis' latest results are for Q2 FY27 (July–September 2026), filed on 28 October 2026: consolidated net loss ₹2.1 crore, wider than the loss of ₹2 crore in Q2 FY26; revenue from operations ₹75.6 crore, down 1.2% year on year.

What is the Chemfab Alkalis revenue and profit in FY26?

In FY26 (April 2025–March 2026), Chemfab Alkalis' consolidated net loss was ₹3.4 crore, narrower than the loss of ₹6.9 crore in FY25, on revenue from operations of ₹311 crore (down 7.0%).

When are the Chemfab Alkalis next results?

Chemfab Alkalis has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

Chemfab Alkalis vs Primo Chemicals: how do they compare?

In FY26, Chemfab Alkalis earned net profit of ₹3.4 crore on revenue of ₹311 crore, against ₹15.4 crore on ₹562 crore for Primo Chemicals. Chemfab Alkalis' operating margin was −0.4% (Primo Chemicals 2.8%) and its return on equity −0.9% (Primo Chemicals 3.9%). At the 30 October 2026 close, Chemfab Alkalis' market capitalisation was ₹419 crore against ₹548 crore for Primo Chemicals.

How does Chemfab Alkalis compare with its peers?

On FY26 consolidated figures, against Primo Chemicals, Plastiblends India and Mangalam Organics: Chemfab Alkalis' operating margin of −0.4% is the lowest of the four (Primo Chemicals 2.8%, Plastiblends India 4.8%, Mangalam Organics 9.7%; peer average 5.8%); its return on equity of −0.9% is the lowest of the four (Primo Chemicals 3.9%, Plastiblends India 8.4%, Mangalam Organics 8.4%; peer average 6.9%).

Where do these Chemfab Alkalis figures come from?

From Chemfab Alkalis' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.